Inhaltsbereich
| 22 Einträge | 1, 2 › » |
Seite 1 / 2
 Druckansicht
|
| OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION. |
| Poglitsch M, Ahmed AH, Resl M, Stoller A, Van Oyen D, Schwager C, Aigner C, Domenig O, Krebs M, Haschke M, Stowasser M |
| Journal of hypertension. 2010 Jan 1. doi: 10.1097/01.hjh.0000501024.99460.c9. pii: 00004872-201609001-01154 |
| PMID: 27643209 |
| Cancer and the renin angiotensin system (RAS): Substantial activation as evidenced by quantification of various RAS peptides and their metabolites in plasma by LC-MS. |
| Loibner H, Poglitsch M, Schwager C, Stranner S, Janzek E, Schuster M, Bauernhofer T, Samonigg H |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e21171 |
| PMID: 28022735 |
| Identifying a disease specific renin-angiotensin-aldosterone system fingerprint in patients with primary adrenal insufficiency. |
| Wolf P, Mayr J, Beiglböck H, Fellinger P, Winhofer Y, Poglitsch M, Gessl A, Kautzky-Willer A, Luger A, Krebs M |
| European journal of endocrinology. 2019 May 1. doi: 10.1530/EJE-19-0086. pii: EJE-19-0086.R1 |
| PMID: 31075757 |
| Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure. |
| Arendse LB, Danser AHJ, Poglitsch M, Touyz RM, Burnett JC, Llorens-Cortes C, Ehlers MR, Sturrock ED |
| Pharmacological reviews. pii: 71/4/539. doi: 10.1124/pr.118.017129 |
| PMID: 31537750 |
| A primary aldosteronism-like phenotype identified with the aldosterone-to-angiotensin II ratio in black men: the SABPA study. |
| van Rooyen JM, Poglitsch M, Huisman HW, Gafane-Matemane LF, Breet Y, Malan L |
| Cardiovascular journal of Africa. 2019 Nov 27. doi: 10.5830/CVJA-2019-059 |
| PMID: 31781716 |
| Plasma homocysteine after laparoscopic Roux-en-Y gastric bypass increases in the early postoperative phase but decreases in the long-term follow-up. A retrospective analysis. |
| Poglitsch M, Geberth A, Krebs M, Langer FB, Mittlboeck M, Prager G |
| Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2019 Dec 9. pii: S1550-7289(19)31123-2. doi: 10.1016/j.soard.2019.11.021 |
| PMID: 31959564 |
| The value of community outreach for a University: a synthesis of trends in higher education The case of the University of Limpopo (ELS 45). |
| van Rooyen JM, Poglitsch M, Huisman HW, Gafane-Matemane LF, Breet Y, Malan L |
| Cardiovascular journal of Africa. 2019 Feb 7. doi: 10.5830/CVJA-2019-059 |
| PMID: 30839050 |
| Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice. |
| Jha S, Taschler U, Domenig O, Poglitsch M, Bourgeois B, Pollheimer M, Pusch LM, Malovan G, Frank S, Madl T, Gruber K, Zimmermann R, Macheroux P |
| The Journal of biological chemistry. 2020 Jun 16. pii: RA120.014183. doi: 10.1074/jbc.RA120.014183 |
| PMID: 32546481 |
| Myocardial Angiotensin Metabolism in End-Stage Heart Failure. |
| Pavo N, Prausmüller S, Spinka G, Goliasch G, Bartko PE, Wurm R, Arfsten H, Strunk G, Poglitsch M, Domenig O, Mascherbauer J, Uyanik-Ünal K, Hengstenberg C, Zuckermann A, Hülsmann M |
| Journal of the American College of Cardiology. pii: S0735-1097(21)00379-X. doi: 10.1016/j.jacc.2021.01.052 |
| PMID: 33832600 |
| Renin Feedback Is an Independent Predictor of Outcome in HFpEF. |
| Binder C, Poglitsch M, Duca F, Rettl R, Dachs TM, Dalos D, Schrutka L, Seirer B, Ligios LC, Capelle C, Eslam RB, Qin H, Hengstenberg C, Bonderman D |
| Journal of personalized medicine. 2021 May 3. pii: jpm11050370. doi: 10.3390/jpm11050370 |
| PMID: 34063595 |
| Combined SGLT-2 and ACE inhibition upregulates the renin-angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double-blind, placebo-controlled exploratory trial. |
| Antlanger M, Domenig O, Kaltenecker CC, Kovarik JJ, Rathkolb V, Müller MM, Schwaiger E, Hecking M, Poglitsch M, Säemann MD, Kopecky C |
| Diabetes, obesity & metabolism. 2022 Jan 4. doi: 10.1111/dom.14639 |
| PMID: 34984822 |
| Tidal Volume-Dependent Activation of the Renin-Angiotensin System in Experimental Ventilator-Induced Lung Injury. |
| Mao X, Krenn K, Tripp T, Tretter V, Reindl-Schwaighofer R, Kraft F, Podesser BK, Zhu Y, Poglitsch M, Domenig O, Abraham D, Ullrich R |
| Critical care medicine. 2022 Feb 22. doi: 10.1097/CCM.0000000000005495. pii: 00003246-900000000-94979 |
| PMID: 35191411 |
| The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis. |
| Dörr K, Kammer M, Reindl-Schwaighofer R, Lorenz M, Marculescu R, Poglitsch M, Beitzke D, Oberbauer R |
| Frontiers in medicine. 2022 Apr 26. doi: 10.3389/fmed.2022.878730. pmc: PMC9086596 |
| PMID: 35559350 |
| Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes. |
| Cruz-López EO, Ren L, Uijl E, Clahsen-van Groningen MC, van Veghel R, Garrelds IM, Domenig O, Poglitsch M, Zlatev I, Rooney T, Kasper A, Nioi P, Foster D, Danser AHJ |
| British journal of pharmacology. 2022 Sep 15. doi: 10.1111/bph.15955 |
| PMID: 36106615 |
| The systemic renin-angiotensin system in COVID-19. |
| Reindl-Schwaighofer R, Hödlmoser S, Domenig O, Krenn K, Eskandary F, Krenn S, Schörgenhofer C, Rumpf B, Karolyi M, Traugott MT, Abrahamowicz A, Tinhof V, Mayfurth H, Rathkolb V, Mußnig S, Schmölz L, Ullrich R, Heinzel A, König F, Binder C, Bonderman D, Strassl R, Puchhammer-Stöckl E, Gorkiewicz G, Aberle JH, Jilma B, Wenisch C, Poglitsch M, Oberbauer R, Zoufaly A, Hecking M |
| Scientific reports. 2022 Nov 22. doi: 10.1038/s41598-022-24628-1. pii: 10.1038/s41598-022-24628-1 |
| PMID: 36418458 |
| The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation. |
| Hartl L, Rumpf B, Domenig O, Simbrunner B, Paternostro R, Jachs M, Poglitsch M, Marculescu R, Trauner M, Reindl-Schwaighofer R, Hecking M, Mandorfer M, Reiberger T |
| Scientific reports. 2023 Jan 18. doi: 10.1038/s41598-023-28239-2. pii: 10.1038/s41598-023-28239-2 |
| PMID: 36653504 |
| Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1. |
| Ortiz C, Klein S, Reul WH, Magdaleno F, Gröschl S, Dietrich P, Schierwagen R, Uschner FE, Torres S, Hieber C, Meier C, Kraus N, Tyc O, Brol M, Zeuzem S, Welsch C, Poglitsch M, Hellerbrand C, Alfonso-Prieto M, Mira F, Keller UAD, Tetzner A, Moore A, Walther T, Trebicka J |
| Cell reports. 2023 Jan 31. doi: 10.1016/j.celrep.2023.112059. pii: S2211-1247(23)00070-0 |
| PMID: 36729833 |
| Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure. |
| Bosch A, Poglitsch M, Kannenkeril D, Kolwelter J, Striepe K, Ott C, Rauh M, Schiffer M, Achenbach S, Schmieder RE |
| ESC heart failure. 2023 Feb 13. doi: 10.1002/ehf2.14313 |
| PMID: 36782339 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. |
| Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| PMID: 26040499 |
| Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. |
| Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R |
| The New England journal of medicine. doi: 10.1056/NEJMoa2104162 |
| PMID: 34320285 |
| 22 Einträge | 1, 2 › » |
Seite 1 / 2
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
